People: Insulet Corp (PODD.O)
19 Jul 2019
Mr. Wayde McMillan has been appointed as Chief Financial Officer, Executive Vice President of the company, effective March 1, 2019. Mr. McMillan is a seasoned executive with more than 20 years of corporate finance and accounting experience. Over the course of his career, he has developed expertise in strategic financial planning and business development at both multi-billion dollar public companies and entrepreneurial start-up ventures. Most recently, Mr. McMillan served as Chief Financial Officer and Vice President of Finance of the Minimally Invasive Therapies Group at Medtronic, where he played a key role in integration efforts following the company's acquisition of Covidien plc in 2015, including reorganizing into the Medtronic Group structure and developing a new global financial plan and strategy.
|Total Annual Compensation,||--|
|Restricted Stock Awards,||--|
|Long-Term Incentive Plans,||--|
|Fiscal Year Total,||--|